Archives of Medical Research
Volume 40, Issue 7 , Pages 582-589 , October 2009

Association Between Serum γ-Glutamyltransferase and Acute Ischemic Nonembolic Stroke in Elderly Subjects

  • Panagiotis Korantzopoulos

      Affiliations

    • Department of Cardiology, Faculty of Medicine, University of Ioannina, Ioannina, Greece
    • ,
  • Petros Tzimas

      Affiliations

    • Department of Internal Medicine, Faculty of Medicine, University of Ioannina, Ioannina, Greece
    • ,
  • Kallirroi Kalantzi

      Affiliations

    • Department of Cardiology, Faculty of Medicine, University of Ioannina, Ioannina, Greece
    • ,
  • Michael Kostapanos

      Affiliations

    • Department of Internal Medicine, Faculty of Medicine, University of Ioannina, Ioannina, Greece
    • ,
  • Konstantinos Vemmos

      Affiliations

    • Acute Stroke Unit, Department of Clinical Therapeutics, Medical School, University of Athens, Athens, Greece
    • ,
  • John Goudevenos

      Affiliations

    • Department of Cardiology, Faculty of Medicine, University of Ioannina, Ioannina, Greece
    • ,
  • Moses Elisaf

      Affiliations

    • Department of Internal Medicine, Faculty of Medicine, University of Ioannina, Ioannina, Greece
    • ,
  • Haralampos Milionis

      Affiliations

    • Department of Internal Medicine, Faculty of Medicine, University of Ioannina, Ioannina, Greece
    • Corresponding Author InformationAddress reprint requests to: Haralampos J. Milionis, MD, Department of Internal Medicine, Faculty of Medicine, University of Ioannina, 451 10 Ioannina, Greece; Phone: +30 2651097509; FAX: +30 2651097016

Received 13 May 2009 ,Accepted 23 July 2009.

References 

  1. Elkind MS. Stroke in the elderly. Mt Sinai J Med. 2003;70:27–37
  2. Bonita R. Epidemiology of stroke. Lancet. 1992;339:342–344
  3. Buckley BM. Healthy ageing: ageing safely. Eur Heart J. 2001;3(suppl N):N6–10
  4. Emdin M, Passino C, Pompella A, Paolicchi A. Gamma-glutamyltransferase as a cardiovascular risk factor. Eur Heart J. 2006;27:2145–2146
  5. Grundy SM. Gamma-glutamyl transferase: another biomarker for metabolic syndrome and cardiovascular risk. Arterioscler Thromb Vasc Biol. 2007;27:4–7
  6. Emdin M, Pompella A, Paolicchi A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation. 2005;112:2078–2080
  7. Franzini M, Corti A, Martinelli B, et al. Gamma-glutamyltransferase activity in human atherosclerotic plaques: biochemical similarities with the circulating enzyme. Atherosclerosis. 2008;395:188–199
  8. Lee DH, Buijsse B, Steffen L, et al. Association between serum gamma-glutamyltransferase and cardiovascular mortality varies by age: the Minnesota Heart Survey. Eur J Cardiovasc Prev Rehabil. 2009;16:16–20
  9. Strasak AM, Kelleher CC, Klenk J, et al. Longitudinal change in serum gamma-glutamyltransferase and cardiovascular disease mortality: a prospective population-based study in 76,113 Austrian adults. Arterioscler Thromb Vasc Biol. 2008;28:1857–1865
  10. Milionis HJ, Liberopoulos E, Goudevenos J, et al. Risk factors for first-ever acute ischemic non-embolic stroke in elderly individuals. Int J Cardiol. 2005;99:269–275
  11. Milionis HJ, Rizos E, Goudevenos JS, et al. Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects. Stroke. 2005;36:1372–1376
  12. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497
  13. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  14. Pompella A, Emdin M, Passino C, et al. The significance of serum gamma-glutamyltransferase in cardiovascular diseases. Clin Chem Lab Med. 2004;42:1085–1091
  15. Lee DH, Blomhoff R, Jacobs DR. Is serum gamma glutamyltransferase a marker of oxidative stress?. Free Radic Res. 2004;38:535–539
  16. Lim JS, Yang JH, Chun BY, et al. Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress?. Free Radic Biol Med. 2004;37:1018–1023
  17. Lee DH, Steffen LM, Jacobs DR. Association between serum gamma-glutamyltransferase and dietary factors: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Clin Nutr. 2004;79:600–605
  18. Frey A, Meckelein B, Weiler-Guttler H, et al. Pericytes of the brain microvasculature express gamma-glutamyl transpeptidase. Eur J Biochem. 1991;202:421–429
  19. Bots ML, Salonen JT, Elwood PC, et al. Gamma-glutamyltransferase and risk of stroke: the EUROSTROKE project. J Epidemiol Community Health. 2002;56(Suppl. 1):i25–29
  20. Ebrahim S, Sung J, Song YM, et al. Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study. BMJ. 2006;333:22
  21. Emdin M, Passino C, Michelassi C, et al. Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Eur Heart J. 2001;22:1802–1807
  22. Fraser A, Harris R, Sattar N, et al. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis. Arterioscler Thromb Vasc Biol. 2007;27:2729–2735
  23. Hozawa A, Okamura T, Kadowaki T, et al. Gamma-glutamyltransferase predicts cardiovascular death among Japanese women. Atherosclerosis. 2007;194:498–504
  24. Jousilahti P, Rastenyte D, Tuomilehto J. Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke. Stroke. 2000;31:1851–1855
  25. Lee DH, Jacobs DR, Gross M, et al. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem. 2003;49:1358–1366
  26. Lee DH, Silventoinen K, Hu G, et al. Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women. Eur Heart J. 2006;27:2170–2176
  27. Ruttmann E, Brant LJ, Concin H, et al. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation. 2005;112:2130–2137
  28. Wannamethee SG, Lennon L, Shaper AG. The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes. Atherosclerosis. 2008;210:168–175
  29. Lee DS, Evans JC, Robins SJ, et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2007;27:127–133
  30. Lee MY, Koh SB, Koh JH, et al. Relationship between gamma-glutamyltransferase and metabolic syndrome in a Korean population. Diabet Med. 2008;25:469–475
  31. Lippi G, Targher G, Montagnana M, et al. Relationship between gamma-glutamyltransferase, lipids and lipoprotein(a) in the general population. Clin Chim Acta. 2007;384:163–166
  32. Sakuta H, Suzuki T, Yasuda H, et al. Gamma-glutamyl transferase and metabolic risk factors for cardiovascular disease. Intern Med. 2005;44:538–541
  33. Shankar A, Li J. Association between serum gamma-glutamyltransferase level and prehypertension among US adults. Circ J. 2007;71:1567–1572

PII: S0188-4409(09)00138-6

doi: 10.1016/j.arcmed.2009.07.012

Archives of Medical Research
Volume 40, Issue 7 , Pages 582-589 , October 2009

Article Tools